Abdominal obesity diagnostics in clinical practice
Abstract
According to the WHO, there are 2 bilUon of obese people worldwide. Obesity prevalence is increasing in developed countries, and also tends to increase in developing regions. Some researchers have demonstrated that abdominal obesity (АО), and not general obesity with increased body mass index (MBI), is associated with raised cardiovascular risk. АО is diagnosed by computed tomography and anthropometry: measurement of waist circumference, waist/hips circumference ratio, sagittal abdominal diameter (SAD). SAD is linked to coronary risk and insulin resistance; therefore, is can be used for identifying obese patients with high risk of type 2 diabetes mellitus and coronary heart disease.
About the Authors
E. N. Vorobyeva
Altay State Medical University
Russian Federation
Russian Federation
I. V. Osipova
Altay State Medical University
Russian Federation
Russian Federation
N. G. Veselovskaya
Altay State Medical University
Russian Federation
Russian Federation
N. I. Mordvinova
Altay Region Cardiology Dispanser. Barnaul
Russian Federation
Russian Federation
R. I. Vorobyev
Altay State Medical University
Russian Federation
Russian Federation
References
1. Allison D.B., Fontaine K.R., Manson J.E. Annual Deaths Attributable to Obesity in the United States. JAMA 1999; 282: 1530-8.
2. Asayama K., Dobashi K., Hayashibe H. Threshold values of visceral fat measures and their anthropometric alternatives for metabolic derangement in Japanese obese boys. Int J Obes 2002; 26: 208-13.
3. Anjana M., Sandeep S., Deepa R. Visceral and central abdominal fat and anthropometry in relation diabetes in asian Indians. Diabetes Care 2004; 27: 2948-53.
4. Empana J.P., Charles M.A., Jouven X. Sagittal abdominal diameter and risk of sudden death in asymptomatic middle-aged men. Circulation 2004; 110: 2781-5.
5. Ferrannini E., Natali A., Bell P. Insulin resistance and hypersecretion in obesity: European Group for the Study of Insulin Resistance (RGIR). Clin Invest 1997; 100: 1166-73.
6. Field A.E., Coakkley E.N., Must A. Impact of overweight on the risk of developing common chronic diseases during a 10 year period. Arch Inter Med 2001; 161: 1581-6.
7. Flegal K.M., Carrol M.D., Johnson C.L. Prevalence and trends in obesity among U.S. adults. JAMA 2002; 288: 1723-7.
8. Grundy S.M., Brewer H.B., Cleeman J.I., et al. Definition of MetaboKc Syndrome. Circulation 2004; 109: 433-8.
9. Hubert H.B., Feinleib M., McNamara P.T. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants of the Framingham Heart Study. Circulation 1983; 67: 968-77.
10. Han T.S., van Leer E.M., Seidell J.C. Waist circuference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 1995; 311: 1401-5.
11. Hu H.B., Manson J.E., Stampfer M.J. Diet, lifestyle and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345: 790-7.
12. Hwu C.M., Hsiao C.F., Sheu W.H. Sagittal abdominal diameter is associated with insulin sensitivity in Chinese hypertensive patients and their siblings. J Hum Hypertens 2003; 17: 193-8.
13. Kvist H., Chowdhury B., Grangard U. Total and visceral adiposetissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am JCKnNutrl988;48: 1351-61.
14. Kahn H.S., Austin H., Williamson D.F. Simple anthropometiic indices associated with ischemic heart disease. J CUn Epidemiol 1996; 49: 1017-24.
15. Kahn H.S., Simoes E.J., Koponen M. The abdominal diameter index and sudden coronary deathinmen. Am J Cardiol 1996; 78: 961-4.
16. Kumlin L., Dimberg L. Ratio of abdominal saggital diameter to height is strong indicator of coronary risk. BMJ 1997; 314: 830-6.
17. Lean M.E., Han T.S., Morrison C.E. Waist circumference as a measure for indicating need for weight management. BMJ 1995; 311: 158-61.
18. Lean M.E., Han T.S., Seidell J.C. Impairment of health and quality of Ufe in people mith large waist circumference. Lancet 1998; 351:853-6.
19. Lemieux S., Prudhomme D., Tremblay F. Anthropometiic correlates to changes in visceral adipose tissue over 7 years women. Int J Obes Relat Metab Disord 1996; 20: 618-24.
20. Lamarche B., Tchernof A., Mauriege P. Fasting insulin and apoKpoprotein В levels and low density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998; 279: 1955-61.
21. Lemieux I., Pascot A., CouiUard C. Hypertriglyceridemic waist. A marker of the atherogenic metabolic triad in men? Circulation 2000; 102:179-84.
22. Lofgren I., Herron K., Zern T. Waist Circumference Is a Better Predictor than Body Mass Index of Coronary Heart Disease Risk inOverweight Premenopausal Women. J Nuti 2004; 134: 1071-6.
23. Nieves D.J., Спор M., Retzlaff B., et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largrly attributable to intia-abdominal fat. Diabetes 2003; 52: 172-9.
24. Ohrval M., Berglund L., Vessby B. Sagittal abdominal diameter compared mith other anthropometiic measurements in relation to cardiovascular risk. Int J Obes 2000; 24: 497-501.
25. Poliot M.C., Despers J.P., Nadeau A. Visceral obesity in men. Associations with glucose tolerance, plasma insulin and lipoprotein levels. Diabetes 1992; 41: 826-34.
26. Poliot M.C., Despers J.P., Lemieux S. Waist circumference and abdominal sagittal diameter: best simple anthropometiic indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73(7): 460-8.
27. Popkin B.M. The nutrition transition and its health implications in low-income countiies. Public Health Nuti 1998; 1: 5-21.
28. Richelsen B., Pedersen S.B. Associations between different anthropometric measurements of fatness and metabolic risk parameters in non-obese, healthy middle-aged men. Int J Obes 1995; 19: 169-74.
29. Riserus U., Arnlov J., Brismar K. Sagittal abdominal diameter is a stiong anthropometric marker of insulin resistance and hyper-proinsulinemia in obese men. Diabetes Care 2004; 27: 2041-6.
30. Seidell J.C., Andres R., Sorkin J. The sagittal waist diameter and mortality in men: the Baltimore longitudinal study on aging. Int J Obes 1994; 18: 61-7.
31. Sjostrom C.D., Lissner L., Sjostrom L. Relationship between changes in body composition and changes in cardiovascular risk factors: the SOS intervention study: Swedish Obese Subjects. Obes Res 1997; 5: 519-30.
32. Tchernof A., Lamarche B., Pruhomme D. The dense LDL phenotype. Association with plasma Kpiprotein levels, visceral obesity and hyperinsuUnemia in men. Diabetes Care 1996; 19: 629-37.
33. Tank L.B., Bagger Y.Z., Qin G., Alexandersen P. Enlarged waist combined with elevated tiiglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 2005; 111: 1883-90.
34. Vagua J. La differenciation sexueUe, facteur determinant des formes de lobesite. Press Med 1947; 30: 339-40.
35. Weidner M.D., Gavigan K.E., Tyndall G.L. Which anthropometiic indices of regional adiposity are related to the insulin resistance of aging? Int J Obes 1995; 19: 325-30.
36. World Health Organization. Obesity -prevention and managing the global epidemic. WHO Report 1999.
Review
For citations:
Vorobyeva E.N., Osipova I.V., Veselovskaya N.G., Mordvinova N.I., Vorobyev R.I. Abdominal obesity diagnostics in clinical practice. Cardiovascular Therapy and Prevention. 2006;5(8):74-78. (In Russ.)
Views:
1197
Email this article 
